The Deloitte report found that 83% of life sciences and healthcare C-suite executives are committed to improving health equity by 2024, with 47% planning to increase investments in this area. The study, which surveyed 53 health equity leaders and 121 executives, identified regulatory pressures, patient engagement, and a focus on social determinants as key drivers for health equity. However, budget constraints, workforce staffing challenges, and competing priorities were listed as headwinds. Deloitte outlined five factors expected to influence health equity initiatives in 2024, including the impact of artificial intelligence, the importance of community engagement in clinical trials, the need for diverse workforce recruitment, ecosystem collaborations, and the necessity for improved research capabilities.
Source link
Report: Improving Health Equity is a Top-10 Goal for Most Healthcare Execs in 2024
